Matthew Walker analyst CREDIT SUISSE

Currently out of the existing stock ratings of Matthew Walker, 5 are a SELL (12.82%), 7 are a HOLD (17.95%), 27 are a BUY (69.23%).

Matthew Walker

Work Performance Price Targets & Ratings Chart

Analyst Matthew Walker, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 83.89% that have a potential upside of 86.15% achieved within 944 days.

Matthew Walker’s has documented 68 price targets and ratings displayed on 5 stocks. The coverage is on the Communication Services sector.

Most recent stock forecast was given on RELX, Relx PLC ADR at 08-Sep-2023.

Wall Street Analyst Matthew Walker

Analyst best performing recommendations are on UBS (UBS GROUP AG).
The best stock recommendation documented was for RELX (RELX PLC ADR) at 9/8/2023. The price target of $37.58 was fulfilled within 96 days with a profit of $5.71 (17.92%) receiving and performance score of 1.87.

Average potential price target upside

RELX Relx PLC ADR WPP WPP PLC ADR PSO Pearson PLC ADR UBS UBS Group AG VIV Telefonica Brasil SA ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Oct-2023

1 years 4 months 14 days ago
(06-Jun-2025)

3/3 (100%)

$4.59 (11.73%)

77

Buy Since 09-Apr-2020

1 years 5 months 23 days ago
(27-Apr-2025)

14/14 (100%)

$6.68 (20.62%)

321

Buy Since 09-Oct-2023

1 years 6 months 4 days ago
(16-Apr-2025)

2/2 (100%)

$44.16 (0.00%)

119

Buy Since 18-Feb-2025

$57

$25.66 (81.88%)

1 years 8 months 2 days ago
(18-Feb-2025)

0/1 (0%)

$6.9 (13.77%)

Hold Since 28-Jun-2023

$39.12

2 years 3 months 16 days ago
(04-Jul-2024)

4/4 (100%)

$2.39 (6.51%)

472

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Matthew Walker?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?